“…Recent developments of DNA sequencing technology and whole genome studies implicated that mutations play a vital role in the genetic architecture of schizophrenia and implicated in several molecular pathways, including chromatin regulation, activity-regulated cytoskeleton, postsynaptic density, and N-methyl-D-aspartate (NMDA) receptor, which are associated with schizophrenia [14]. Schizophrenia-network pathway complex analysis (SCZ-NPCA) has included enrichment analysis which demonstrates the role of the implicated pathways in schizophrenia, such as transcription activity, signaling pathway, cancer-related pathway, tumor suppression, coagulation, insulin secretion, cell cycle, cell diferentiation, and apoptosis [5].…”